RASICA Trademark

Trademark Overview

On Monday, March 24, 2025, a trademark application was filed for RASICA with the United States Patent and Trademark Office. The USPTO has given the RASICA trademark a serial number of 99100351. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, September 2, 2025. This trademark is owned by Hangzhou Adlai Nortye Biopharma Co., Ltd.. The RASICA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical product evaluation; Testing of pharmaceuticals; Drug discovery services; Pharmaceutical drug development services; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical research and development; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of cancer
rasica

General Information

Serial Number99100351
Word MarkRASICA
Filing DateMonday, March 24, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, September 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, September 23, 2025

Trademark Statements

Description of MarkThe mark consists of the word "RASICA" in stylized form, where the letter "I" is in lower case, and the other letters of the word are capitalized.
Goods and ServicesMedical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical product evaluation; Testing of pharmaceuticals; Drug discovery services; Pharmaceutical drug development services; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical research and development; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of cancer

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 24, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHangzhou Adlai Nortye Biopharma Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHangzhou 311121
CN

Trademark Events

Event DateEvent Description
Monday, March 24, 2025NEW APPLICATION ENTERED
Friday, August 22, 2025ASSIGNED TO EXAMINER
Friday, August 22, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 17, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 11, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 24, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

rasica research pharmaceutical medical development others drug scientific trials pharmaceuticals clinical